Loxo Oncology (NDAQ:LOXO) Got Higher Citigroup Rating; 2 Analysts Covering Seadrill Ltd (SDRL)

June 5, 2017 - By Dolores Ford

Among 10 analysts covering Seadrill (NYSE:SDRL), 2 have Buy rating, 3 Sell and 5 Hold. Therefore 20% are positive. Seadrill had 21 analyst reports since August 20, 2015 according to SRatingsIntel. The stock of Seadrill Ltd (NYSE:SDRL) earned “Buy” rating by Vetr on Monday, August 31. The stock of Seadrill Ltd (NYSE:SDRL) has “Strong-Buy” rating given on Thursday, August 20 by Vetr. Scotia Capital maintained the shares of SDRL in report on Tuesday, September 1 with “Sector Perform” rating. The stock has “Underweight” rating by JP Morgan on Friday, January 15. Bank of America maintained the shares of SDRL in report on Saturday, August 29 with “Neutral” rating. The stock has “Perform” rating by Oppenheimer on Monday, November 30. The stock of Seadrill Ltd (NYSE:SDRL) has “Buy” rating given on Wednesday, September 2 by Vetr. The rating was downgraded by Vetr to “Strong-Buy” on Friday, August 28. Seaport Global Securities downgraded the stock to “Neutral” rating in Friday, December 18 report. The stock of Seadrill Ltd (NYSE:SDRL) earned “Sector Perform” rating by Howard Weil on Tuesday, September 1. See Seadrill Ltd (NYSE:SDRL) latest ratings:

29/05/2017 Broker: ValuEngine Old Rating: Buy New Rating: Hold Downgrade

Among 2 analysts covering Loxo Oncology Inc (NDAQ:LOXO), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Loxo Oncology Inc had 2 analyst reports since March 10, 2017 according to SRatingsIntel. The stock of Loxo Oncology Inc (NASDAQ:LOXO) earned “Overweight” rating by Morgan Stanley on Monday, April 3. Citigroup downgraded the shares of LOXO in report on Friday, March 10 to “Neutral” rating.

Investors sentiment increased to 2.41 in 2016 Q4. Its up 0.31, from 2.1 in 2016Q3. It increased, as 7 investors sold Loxo Oncology Inc shares while 15 reduced holdings. 20 funds opened positions while 33 raised stakes. 20.34 million shares or 0.53% less from 20.45 million shares in 2016Q3 were reported. 4.03M are held by Aisling Cap Ltd Liability Corp. Proshare Advisors Ltd Limited Liability Company has 16,463 shares. Blackrock Fund Advsr stated it has 0% of its portfolio in Loxo Oncology Inc (NASDAQ:LOXO). Moreover, Ontario Teachers Pension Plan Board has 0% invested in Loxo Oncology Inc (NASDAQ:LOXO). Axa stated it has 203,087 shares. Polar Cap Llp invested in 70,182 shares or 0.04% of the stock. Balyasny Asset Ltd has invested 0.01% of its portfolio in Loxo Oncology Inc (NASDAQ:LOXO). Bp Public Ltd invested 0.01% in Loxo Oncology Inc (NASDAQ:LOXO). Great West Life Assurance Can has 1,000 shares. Invesco Ltd holds 0% or 28,269 shares. Goldman Sachs Group Inc Inc accumulated 0% or 42,133 shares. Wellington Mgmt Grp Llp, Massachusetts-based fund reported 1.81M shares. Trexquant Investment Lp holds 10,969 shares. Awm has invested 1.13% of its portfolio in Loxo Oncology Inc (NASDAQ:LOXO). Massachusetts-based Rhumbline Advisers has invested 0% in Loxo Oncology Inc (NASDAQ:LOXO).

Since December 19, 2016, it had 1 buy, and 3 insider sales for $4.11 million activity. Flaherty Keith T. sold $300,517 worth of Loxo Oncology Inc (NASDAQ:LOXO) on Tuesday, February 21. 160,000 shares were bought by AISLING CAPITAL III LP, worth $4.96 million on Tuesday, January 10.

About 4.89 million shares traded or 2652.93% up from the average. Loxo Oncology Inc (NDAQ:LOXO) has risen 77.12% since June 5, 2016 and is uptrending. It has outperformed by 60.42% the S&P500.

Loxo Oncology, Inc. is a biopharmaceutical company. The company has market cap of $1.98 billion. The Firm is focused on development of medicines for patients with genetically defined cancers. It currently has negative earnings. The Company’s pipeline focuses on cancers that are dependent on single gene abnormalities, such that a single drug has the potential to treat the cancer with dramatic effect.

Seadrill Limited is an offshore drilling contractor providing offshore drilling services to the gas and oil industry. The company has market cap of $206.78 million. The Company’s primary business is the ownership and operation of drillships, semi-submersible rigs and jack-up rigs for activities in shallow-, mid-, deep-, and ultra deepwater areas, and in benign and harsh environments. It currently has negative earnings. The Company’s divisions are Floaters and Jack-ups.

About 4.64 million shares traded. Seadrill Ltd (NYSE:SDRL) has declined 83.13% since June 5, 2016 and is downtrending. It has underperformed by 99.83% the S&P500.